Counting Cancer-busting Oxygen Molecules
News Feb 08, 2016
The research is based on the successful quantification of singlet oxygen produced during photodynamic therapy for cancer. Singlet oxygen molecules (a highly reactive form of oxygen) are able to kill or inhibit growth of cancer cells in the body due to their toxicity.
Co-lead author on the paper, Ewa Goldys, Deputy Director of the CNBP and Professor at Macquarie University explained, “Photodynamic therapy is where light sensitive compounds are placed near diseased cells, then activated by light, producing short lived molecular by-products that can destroy or damage the cells being targeted.”
“In this case, X-rays (a form of light) were used to stimulate cerium fluoride (CeF3) nanoparticles which had been placed near a group of cells. Singlet oxygen was produced as a by-product of the X-ray and CeF3 interaction, which was then successfully measured.”
Goldys believes the research is significant, as this is the first time that anyone has been able to quantify accurately, the number of singlet oxygen molecules produced in this type of procedure.
“Singlet oxygen molecules are a far more reactive form of oxygen but they can only kill cancer cells if generated in sufficient quantity”, said Goldys.
“In our testing we established that therapeutic radiation dose X-rays, produce enough singlet oxygen molecules to be effective in photodynamic therapy.”
According to Goldys, photodynamic therapy has traditionally utilised near-infrared or visible light which has been unable to penetrate far into the body, limiting its use to cancer treatment, on or near the surface of the skin.
“We’re looking to target cancer cells deeper in the body hence the use of X-rays, which can really penetrate into deeper levels of tissue, and are already used in medical diagnostic and therapy.’
Concluded Goldys, “What we’ve shown through our measurements is the applicability of the photodynamic therapy approach to effectively treat tumours within.”
“The beauty of this type of treatment is that it uses different biological pathways to kill cells as compared to chemotherapy, radiotherapy and other current cancer practices.
“Deep tissue photodynamic therapy will potentially provide new treatment options for the cancer patients of the future.”
Next steps with this research will see differing nanoparticles tested and measured, for effectiveness in singlet oxygen production.
Nano-tech Diagnostic Can Indicate Cancer or Thrombotic Risk in One Drop of BloodNews
A team of international researchers led by Professor Martin Hegner, Investigator in CRANN and Trinity’s School of Physics, have developed an automated diagnostic platform that can quantify bleeding – and thrombotic risks – in a single drop of blood, within seconds.READ MORE
High Fruit and Veg Consumption May Reduce Breast Cancer RiskNews
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers from Harvard T.H. Chan School of Public Health.READ MORE
Kidney Cancer Driver Could Lead to New Treatment StrategyNews
Scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new cancer-driving pathway.READ MORE